Product NewsGenomic Health and Almac Group Enter Exclusive In-Licensing Agreement to Develop and Commercialize Anthracycline Chemotherapy Benefit Test for High Risk Breast Cancer
Product NewsTrophos Completes Pivotal Phase II/III Study of Olesoxime in Spinal Muscular Atrophy (SMA)
Product NewsXention and Servier Announce a Cardiovascular Collaboration to Further Develop a Selective Kv1.5 Modulator for the Treatment of Atrial Fibrillation
Industry NewsMRC Technology and Boston University Collaborate to Develop anti-IL-16 Antibody for Treatment of Inflammatory Conditions
Product NewsBoreal Genomics Secures $18 Million Series C Financing to Expand Commercial Operations in Life Science Research Market and Launch Clinical Application for Non-Invasive Tumor Profiling
Product NewsAddex ADX71441 Dose Dependently Reduced PMP22 Expression Comparable to Baclofen in a Pre-Clinical Transgenic Model of Charcot-Marie-Tooth 1A Disease
Product NewsSciformix To Showcase New Clinical Research and Post-Approval Support Capabilities at DIA Clinical Forum
Product NewsTrophos Announces Final Patient Completion of Phase II Proof-of-Concept Study of TRO40303 in Patients Treated for Acute Myocardial Infarction
Product NewsRubicon's ThruPLEX™-FD Prep Kits Enable Study Showing Liquid Biopsy Can Track Cancer Resistance
Product NewsISA Pharmaceuticals Presents Novel Data at the European Cancer Congress 2013: Strong Synergies Between Cancer Vaccine ISA101 and Chemotherapy
Product NewsTheorem Clinical Research Puts Medical Device Expertise on Display at Outsourcing in Clinical Trials New England
